Global electronics giant Samsung acquires imaging devices maker NeuroLogica in a stealthy deal that further expands Samsung's growing interest in the medtech space.

Technology titan Samsung Electronics (LON:BC94) made new moves in the medical device space with the stealthy buyout of Danvers, Mass.-based imaging devices maker NeuroLogica.
The companies didn't provide many details on the closed-doors deal, but the acquisition fits into Samsung's larger vision to "explore new avenues of growth in the healthcare business."
Samsung solidified its interest in the medical device space in May 2011 when it formed a new corporate identity for its medtech division through a collaboration with Korea-based Medison Co., forming Samsung Medison.
"We will dramatically increase our investment in research and development, and will do our best to promote human health and happiness by securing the best in scientific and human resources in the medical device industry," Samsung Medison CEO Sang-Won Bang had said in prepared remarks.
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...